Geoffrey Guy,Stephen Wright,Michael Anthony Cawthorne,Saoirse OSullivan
申请号：
US13735108
公开号：
US20130245110A1
申请日:
2013.01.07
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention relates to the use of CBD alone or in combination with another cannabinoid, in the manufacture of a pharmaceutical or neutraceutical formulation for use in controlling cholesterol levels in a subject. It also relates to the use of THCV alone or in combination with another cannabinoid, in the manufacture of a pharmaceutical or neutraceutical formulation for use in increasing energy expenditure in a subject. Furthermore the CBD alone or in combination with another cannabinoid or the THCV alone or in combination with another cannabinoid are used as part of a regime to manage or treat type I or II diabetes, obesity, dyslipidaemia, related metabolic disorders and cardiovascular disease.
